Stock ASND ASCENDIS PHARMA A/S
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Ascendis Pharma A/S

Equities

ASND

US04351P1012

Real-time Estimate Cboe BZX
Other stock markets
 18:34:34 01/05/2024 BST 		5-day change 1st Jan Change
141.2 USD +1.97% Intraday chart for Ascendis Pharma A/S -1.90% +11.52%
04-29 European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading MT
04-26 European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4% MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism
Ascendis Pharma A/S Announces United Kingdom's MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading
Ascendis Pharma A/S Appoints Mads Bodenhoff as Senior Vice President, Finance Principal Accounting Officer
European Equities Traded in the US as American Depositary Receipts Set to End Week Higher in Friday Trading
European Equities Traded in US as American Depositary Receipts Move Slightly Higher in Friday Trading
Ascendis Pharma Q4 Net Loss Narrows, Revenue Rises
Ascendis Pharma A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Ascendis Pharma A/S Reports Earnings Results for the Full Year Ended December 31, 2023
European Equities Traded in the US as American Depositary Receipts Make Modest Gains in Thursday Trading
Ascendis Pharma A/S Launches 2nd TransCon Product: YORVIPATH Now Available in Germany and Austria for Adults with Chronic Hypoparathyroidism
European Equities Traded in the US as American Depositary Receipts Move Lower in Tuesday Trading
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ASND Stock
  4. News Ascendis Pharma A/S
  5. Other languages